Delivery Order SPE2DB22D2206-SPE2DB25FEL09

Award Date 11/26/24
Potential Completion Date 11/27/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $2,018.28 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of VALTOCO 10 MG NASAL SPRAYS, a critical care medication, with an ultimate completion date of August 22, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of VALTOCO 15 MG nasal sprays. The $2,124.34 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a...
This federal contract award, with ID SPE2DB22D1041|SPE2DB25FTYA1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,394.78 delivery order is for the supply of VALTOCO 10 MG NASAL SPRAYS, a pharmaceutical product. The contract is a Firm Fixed Price (FFP) type, with an ultimate completion date of October 24, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,458.90 for the supply of VALTOCO 20 MG NASAL SPRAYS. The contract, which has no set-aside designation, is funded by the Defense Logistics Agency, a defense agency. The award has a completion date of May 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,877.83 firm-fixed-price contract is for the delivery of VALTOCO 15 MG nasal sprays and has a completion date of May 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,672.48, is for the delivery of Valtoco 10 mg nasal sprays. This is a firm fixed-price delivery order that does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 10 mg VALTOCO nasal sprays. The $1,254.36 firm fixed-price delivery order has a completion date of November 8, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $1,129.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALTOCO 10 MG NASAL SPRAYS, a pharmaceutical product, with a performance period ending on May 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,364.45 fixed-price delivery order is for the supply of VALTOCO 10 MG nasal sprays, with an ultimate completion date of October 21, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
This federal contract award, valued at $1,247.06, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the delivery of 4565133484 - VALTOCO 15 MG NASAL SPRAYS. The contract is a Firm Fixed Price Delivery Order with a completion date of July 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEL09
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VALTOCO 10 MG NASAL SPRAYS. The firm-fixed-price delivery order, valued at $1,979.40, has an ultimate completion date of November 27, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/25/25, 9:49 AM